Skip to content
healthcare.dev

Lacosamide

NDC 65219-204, Lacosamide, injection, from Fresenius Kabi USA, LLC.

Product NDC
65219-204
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214677
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE10 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
65219-204-206521902042010 VIAL, SINGLE-DOSE in 1 CARTON (65219-204-20) / 20 mL in 1 VIAL, SINGLE-DOSE (65219-204-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/419ff519-2b19-4fb9-adfa-868ba0229407

Use it

Look up 65219-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.